1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
90.78%
Revenue growth above 1.5x 5715.T's 9.19%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
89.02%
Gross profit growth above 1.5x 5715.T's 9.83%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
204.72%
EBIT growth above 1.5x 5715.T's 86.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
370.86%
Operating income growth at 50-75% of 5715.T's 687.90%. Martin Whitman would doubt the firm’s ability to compete efficiently.
521.83%
Net income growth above 1.5x 5715.T's 43.16%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
522.24%
EPS growth above 1.5x 5715.T's 43.12%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
522.24%
Diluted EPS growth above 1.5x 5715.T's 43.12%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
436.73%
OCF growth above 1.5x 5715.T's 160.59%. David Dodd would confirm a clear edge in underlying cash generation.
436.73%
FCF growth above 1.5x 5715.T's 151.57%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-88.96%
Negative 10Y revenue/share CAGR while 5715.T stands at 67.33%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-88.96%
Negative 5Y CAGR while 5715.T stands at 67.33%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-88.96%
Negative 3Y CAGR while 5715.T stands at 67.33%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-80.93%
Negative 10Y OCF/share CAGR while 5715.T stands at 699.27%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-80.93%
Negative 5Y OCF/share CAGR while 5715.T is at 699.27%. Joel Greenblatt would question the firm’s operational model or cost structure.
-80.93%
Negative 3Y OCF/share CAGR while 5715.T stands at 699.27%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
106.67%
Similar net income/share CAGR to 5715.T's 110.11%. Walter Schloss would see parallel tailwinds or expansions for both firms.
106.67%
5Y net income/share CAGR similar to 5715.T's 110.11%. Walter Schloss might see both on parallel mid-term trajectories.
106.67%
3Y net income/share CAGR similar to 5715.T's 110.11%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-87.23%
Negative equity/share CAGR over 10 years while 5715.T stands at 2.96%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-87.23%
Negative 5Y equity/share growth while 5715.T is at 2.96%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-87.23%
Negative 3Y equity/share growth while 5715.T is at 2.96%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-9.55%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
31.28%
Positive BV/share change while 5715.T is negative. John Neff sees a clear edge over a competitor losing equity.
-20.50%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.